Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Braemar, Inc. — Predicate Candidate Screening

5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

28 daysmedian FDA review time
72 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K081444BRAEMAR FUSION WIRELESS - AMBULATORY ECG ARRHYTHMIA MONITORIBraemar, Inc.2008-07-31700
K072008BRAEMAR ER900 WIRELESS SERIES ARRHYTHMIA EVENT RECORDERBraemar, Inc.2007-10-03722
K071733DL900 SERIES HOLTER RECORDERBraemar, Inc.2007-07-24280
K071011MODIFICATION TO: BRAEMAR ER900 SERIES ENHANCED ALGORITHM ECGBraemar, Inc.2007-04-27170
K042469BRAEMAR ER800 SERIES ENHANCED ALGORITHM EVENT RECORDERBraemar, Inc.2004-10-06230

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda